Lowering Healthcare Costs and Expanding Access

Working to lower healthcare costs and expand access to quality care continues to be a top priority for me. Our healthcare system must work better for America’s middle class and for small businesses. Having lived with Type-1 diabetes for more than 30 years, I understand the costs and complexities of healthcare. I will continue to advocate for a thoughtful, multi-faceted approach to healthcare reform that addresses costs while protecting doctor and coverage choices. The Affordable Care Act (ACA) needs to be made better and more affordable, not repealed.  That’s why I opposed every attempt to repeal or undermine the ACA while supporting multiple improvements.  But we must also work to lower insurance premiums and rein in the costs of prescription drugs, hospitals, and doctors for everyone.  This is necessary and achievable, but it is not simple. It requires well thought-out solutions, not slogans.

  • Ensure America keeps its promises to our seniors

  • Pass into law H.R. 3 and H.R. 5039 to lower the cost of prescription drugs in Medicare (see below)

  • Oppose benefit cuts

  • Safeguard the Medicare Trust Fund

  • Get the House-approved H.R. 3, the Lower Drug Costs Now Act, passed by the Senate and signed into law so that Medicare can negotiate better drug prices that are in line with what pharmaceutical companies charge for the same drugs in other countries

    • Makes the lower drug prices negotiated by Medicare also available to Americans with private insurance

    • Create a new $2,000 out-of-pocket limit on prescription drug costs for Medicare beneficiaries

  • Pass H.R. 5039, the Life-Sustaining Prescription Drug Relief Act, authored by Rep. Lipinski, to combat price gouging on life-sustaining prescription drugs

    • Gives the federal government the tools to lower the cost of all life-sustaining drugs for seniors and others on Medicare by negotiating for prices that are similar to those charged in other countries. Work cover medications such as insulin, EpiPens, and anti-seizure drugs.

  • Put an end to “surprise billing” where a provider or hospital not covered by a patient’s insurance charges a high out-of-network price

  • Encourage states to institute a privately-run public option plan in ACA exchanges similar to the State of Washington’s new law

  • Strengthen disclosure to states of all prices charged by providers to create transparency, accountability, and fair pricing in the market

  • Institute a reinsurance program to cut premiums 10% with House passage of H.R. 1425, the State Healthcare Premium Reduction Act

  • Require the payment of cost-share reduction payments stopped by the Trump Administration, while ensuring assistance for premiums is not harmed.

  • Increase funding to states to help make insurance offerings more transparent and uniform and to promote sign-ups by getting the Senate to pass H.R. 987, the House-approved Strengthening Healthcare and Lowering Prescription Drug Costs Act

  • Build on the successes of states that have already opted into Medicaid expansion to fill the historical Medicaid eligibility gaps for low-income adults

  • Remove the original time constraints permitted for enhanced federal funding and encourage the remaining states to opt-in by passing H.R. 584, the Incentivizing Medicaid Expansion Act

Dan Lipinski for Congress
Post Office Box 520
Western Springs, IL 60558
(773) 284-8566
Stay connected with our campaign and volunteer opportunities…